Similar articles for PMID: 28939591

Year	Number of Results
2005	1
2006	3
2007	1
2008	6
2009	10
2010	12
2011	4
2012	10
2013	15
2014	21
2015	17
2016	22
2017	20
2018	30
2019	17
2020	15
2021	26
2022	19
2023	6
2024	0

1

miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.

Zheng L, Meng X, Li X, Zhang Y, Li C, Xiang C, Xing Y, Xia Y, Xi T. Zheng L, et al. FASEB J. 2018 Feb;32(2):588-600. doi: 10.1096/fj.201700461RR. Epub 2018 Jan 4. FASEB J. 2018. PMID: 28939591

2

MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.

Cui J, Yang Y, Li H, Leng Y, Qian K, Huang Q, Zhang C, Lu Z, Chen J, Sun T, Wu R, Sun Y, Song H, Wei X, Jing P, Yang X, Zhang C. Cui J, et al. Oncogene. 2015 Jul 23;34(30):3895-907. doi: 10.1038/onc.2014.430. Epub 2014 Dec 22. Oncogene. 2015. PMID: 25531331

3

Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.

Zhang X, Zhang B, Zhang P, Lian L, Li L, Qiu Z, Qian K, Chen A, Liu Q, Jiang Y, Cui J, Qi B. Zhang X, et al. PLoS One. 2019 May 23;14(5):e0217181. doi: 10.1371/journal.pone.0217181. eCollection 2019. PLoS One. 2019. PMID: 31120927 Free PMC article.

4

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.

Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ. Zhao JJ, et al. J Biol Chem. 2008 Nov 7;283(45):31079-86. doi: 10.1074/jbc.M806041200. Epub 2008 Sep 12. J Biol Chem. 2008. PMID: 18790736 Free PMC article. Retracted.

5

Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.

Xu X, Lv YG, Yan CY, Yi J, Ling R. Xu X, et al. Biochem Biophys Res Commun. 2016 Oct 28;479(4):893-900. doi: 10.1016/j.bbrc.2016.09.087. Epub 2016 Sep 28. Biochem Biophys Res Commun. 2016. PMID: 27693788

6

Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro.

Xiong H, Jin X, You C. Xiong H, et al. Med Sci Monit. 2018 Nov 4;24:7883-7890. doi: 10.12659/MSM.910647. Med Sci Monit. 2018. PMID: 30391994 Free PMC article.

7

Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.

Wei Y, Lai X, Yu S, Chen S, Ma Y, Zhang Y, Li H, Zhu X, Yao L, Zhang J. Wei Y, et al. Breast Cancer Res Treat. 2014 Sep;147(2):423-31. doi: 10.1007/s10549-014-3037-0. Epub 2014 Jul 10. Breast Cancer Res Treat. 2014. PMID: 25007959

8

Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.

Zhu J, Zou Z, Nie P, Kou X, Wu B, Wang S, Song Z, He J. Zhu J, et al. Cell Death Dis. 2016 Nov 3;7(11):e2454. doi: 10.1038/cddis.2016.361. Cell Death Dis. 2016. PMID: 27809310 Free PMC article.

9

HuR facilitates cancer stemness of lung cancer cells via regulating miR-873/CDK3 and miR-125a-3p/CDK3 axis.

Zhang Y, Yang L, Ling C, Heng W. Zhang Y, et al. Biotechnol Lett. 2018 Apr;40(4):623-631. doi: 10.1007/s10529-018-2512-9. Epub 2018 Jan 17. Biotechnol Lett. 2018. PMID: 29344850

10

Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer.

Zheng L, Li X, Meng X, Chou J, Hu J, Zhang F, Zhang Z, Xing Y, Liu Y, Xi T. Zheng L, et al. Mol Cell Endocrinol. 2016 May 15;427:133-42. doi: 10.1016/j.mce.2016.03.012. Epub 2016 Mar 12. Mol Cell Endocrinol. 2016. PMID: 26980484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

223 results

Results by year